Current Fellows in the Integrative Tumor Epidemiology Branch
Meet the fellows in the Integrative Tumor Epidemiology Branch (ITEB) and learn about their work.
Meet the fellows in the Integrative Tumor Epidemiology Branch and learn about their work.
-
Quiera S. Booker, Ph.D., M.P.H.Dr. Booker investigates molecular and social factors that contribute to breast cancer disparities.
-
Li Feng, Ph.D.Dr. Feng studies the etiology of breast cancer, while exploring the associated risk factors and heterogeneity across different populations.
-
Rebecca L. Kelly, Ph.D., M.P.H.Dr. Kelly studies early somatic events in healthy cells and the contribution of germline and environmental factors to their potential progression to cancer.
-
Olivia Lee, Ph.D.Dr. Lee is studying tumor evolution of lung cancer from never-smokers through multi-omic analysis and epidemiologic assessment.
-
Xuan Cindy Li, Ph.D.Dr. Li studies the role of epigenetic changes in lung cancer in non-smokers.
-
Stephanie Ho, B.A.Ms. Ho studies breast cancer survivorship disparities and the intergenerational reproductive health effects of diethylstilbestrol (DES).
-
Ibrahim Hossain Sajal, Ph.D.Dr. Sajal investigates the roles of proteins as mediators of the effects of various risk factors on kidney cancer.
-
Michelle Sodipo, Ph.D., M.S., M.P.H.Dr. Sodipo investigates treatment patterns, endocrine therapy outcomes, and health disparities among breast cancer survivors.
-
Aiswarya Suriaprakash, M.S.Ms. Suriaprakash works on the Sherlock-Lung project.
-
Thi Van Trinh Tran, Ph.D., M.P.H., B.Pharm.Dr. Tran uses pathology and radiology data for risk classifications for lung cancer in never-smokers.
-
Corey Young, Ph.D., M.S.Dr. Young investigates early-stage clonal chromosomal alterations in leukocytes and their potential relevance for hematological cancer risk.
-
Wei Zhao, Ph.D.Dr. Zhao investigates the etiology and progression of lung cancer in never smokers through a comprehensive genomic analysis and clinical and epidemiologic assessment.
-
Shahriar A. Zamani, Ph.D.Dr. Zamani characterizes chromosomal loss across solid tumors.